MCT® can be used in numerous therapeutic areas such as: Malaria, Influenza, Immunotherapy & Cancer
MCT® is available for out licensing and can also be requested for independent evaluation (via Material Transfer Agreements)
The National Institute of Health (NIH) have also listed the MCT® profile on their vaccine adjuvant compendium database (VAC) – Click here
The Vaccine Adjuvant Compendium (VAC) aims to foster collaborations
between NIAID-supported adjuvant researchers and the broader scientific
community to help vaccine developers identify suitable adjuvants